Cargando…

Intranasal Immunization with a Recombinant Avian Paramyxovirus Serotypes 2 Vector-Based Vaccine Induces Protection against H9N2 Avian Influenza in Chicken

Commercial inactivated vaccines against H9N2 avian influenza (AI) have been developed in China since 1990s and show excellent immunogenicity with strong HI antibodies. However, currently approved vaccines cannot meet the clinical demand for a live-vectored vaccine. Newcastle disease virus (NDV) vect...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Wenhao, Dai, Jing, Liu, Jingjing, Guo, Mengjiao, Liu, Xiaowen, Hu, Shunlin, Gu, Min, Hu, Jiao, Hu, Zenglei, Gao, Ruyi, Liu, Kaituo, Chen, Yu, Liu, Xiufan, Wang, Xiaoquan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9144924/
https://www.ncbi.nlm.nih.gov/pubmed/35632659
http://dx.doi.org/10.3390/v14050918
_version_ 1784716166963396608
author Yang, Wenhao
Dai, Jing
Liu, Jingjing
Guo, Mengjiao
Liu, Xiaowen
Hu, Shunlin
Gu, Min
Hu, Jiao
Hu, Zenglei
Gao, Ruyi
Liu, Kaituo
Chen, Yu
Liu, Xiufan
Wang, Xiaoquan
author_facet Yang, Wenhao
Dai, Jing
Liu, Jingjing
Guo, Mengjiao
Liu, Xiaowen
Hu, Shunlin
Gu, Min
Hu, Jiao
Hu, Zenglei
Gao, Ruyi
Liu, Kaituo
Chen, Yu
Liu, Xiufan
Wang, Xiaoquan
author_sort Yang, Wenhao
collection PubMed
description Commercial inactivated vaccines against H9N2 avian influenza (AI) have been developed in China since 1990s and show excellent immunogenicity with strong HI antibodies. However, currently approved vaccines cannot meet the clinical demand for a live-vectored vaccine. Newcastle disease virus (NDV) vectored vaccines have shown effective protection in chickens against H9N2 virus. However, preexisting NDV antibodies may affect protective efficacy of the vaccine in the field. Here, we explored avian paramyxovirus serotype 2 (APMV-2) as a vector for developing an H9N2 vaccine via intranasal delivery. APMV-2 belongs to the same genus as NDV, distantly related to NDV in the phylogenetic tree, based on the sequences of Fusion (F) and hemagglutinin-neuraminidase (HN) gene, and has low cross-reactivity with anti-NDV antisera. We incorporated hemagglutinin (HA) of H9N2 into the junction of P and M gene in the APMV-2 genome by being flanked with the gene start, gene end, and UTR of each gene of APMV-2-T4 to generate seven recombinant APMV-2 viruses rAPMV-2/HAs, rAPMV-2-NPUTR-HA, rAPMV-2-PUTR-HA, rAPMV-2-FUTR-HA, rAPMV-2-HNUTR-HA, rAPMV-2-LUTR-HA, and rAPMV-2-MUTR-HA, expressing HA. The rAPMV-2/HAs displayed similar pathogenicity compared with the parental APMV-2-T4 virus and expressed HA protein in infected CEF cells. The NP-UTR facilitated the expression and secretion of HA protein in cells infected with rAPMV-2-NPUTR-HA. Animal studies demonstrated that immunization with rAPMV-2-NPUTR-HA elicited effective H9N2-specific antibody (6.14 ± 1.2 log2) responses and conferred complete immune protection to prevent viral shedding in the oropharyngeal and cloacal swabs from chickens challenged with H9N2 virus. This study suggests that our recombinant APMV-2 virus is safe and immunogenic and can be a useful tool in the combat of H9N2 outbreaks in chicken.
format Online
Article
Text
id pubmed-9144924
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-91449242022-05-29 Intranasal Immunization with a Recombinant Avian Paramyxovirus Serotypes 2 Vector-Based Vaccine Induces Protection against H9N2 Avian Influenza in Chicken Yang, Wenhao Dai, Jing Liu, Jingjing Guo, Mengjiao Liu, Xiaowen Hu, Shunlin Gu, Min Hu, Jiao Hu, Zenglei Gao, Ruyi Liu, Kaituo Chen, Yu Liu, Xiufan Wang, Xiaoquan Viruses Article Commercial inactivated vaccines against H9N2 avian influenza (AI) have been developed in China since 1990s and show excellent immunogenicity with strong HI antibodies. However, currently approved vaccines cannot meet the clinical demand for a live-vectored vaccine. Newcastle disease virus (NDV) vectored vaccines have shown effective protection in chickens against H9N2 virus. However, preexisting NDV antibodies may affect protective efficacy of the vaccine in the field. Here, we explored avian paramyxovirus serotype 2 (APMV-2) as a vector for developing an H9N2 vaccine via intranasal delivery. APMV-2 belongs to the same genus as NDV, distantly related to NDV in the phylogenetic tree, based on the sequences of Fusion (F) and hemagglutinin-neuraminidase (HN) gene, and has low cross-reactivity with anti-NDV antisera. We incorporated hemagglutinin (HA) of H9N2 into the junction of P and M gene in the APMV-2 genome by being flanked with the gene start, gene end, and UTR of each gene of APMV-2-T4 to generate seven recombinant APMV-2 viruses rAPMV-2/HAs, rAPMV-2-NPUTR-HA, rAPMV-2-PUTR-HA, rAPMV-2-FUTR-HA, rAPMV-2-HNUTR-HA, rAPMV-2-LUTR-HA, and rAPMV-2-MUTR-HA, expressing HA. The rAPMV-2/HAs displayed similar pathogenicity compared with the parental APMV-2-T4 virus and expressed HA protein in infected CEF cells. The NP-UTR facilitated the expression and secretion of HA protein in cells infected with rAPMV-2-NPUTR-HA. Animal studies demonstrated that immunization with rAPMV-2-NPUTR-HA elicited effective H9N2-specific antibody (6.14 ± 1.2 log2) responses and conferred complete immune protection to prevent viral shedding in the oropharyngeal and cloacal swabs from chickens challenged with H9N2 virus. This study suggests that our recombinant APMV-2 virus is safe and immunogenic and can be a useful tool in the combat of H9N2 outbreaks in chicken. MDPI 2022-04-28 /pmc/articles/PMC9144924/ /pubmed/35632659 http://dx.doi.org/10.3390/v14050918 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Yang, Wenhao
Dai, Jing
Liu, Jingjing
Guo, Mengjiao
Liu, Xiaowen
Hu, Shunlin
Gu, Min
Hu, Jiao
Hu, Zenglei
Gao, Ruyi
Liu, Kaituo
Chen, Yu
Liu, Xiufan
Wang, Xiaoquan
Intranasal Immunization with a Recombinant Avian Paramyxovirus Serotypes 2 Vector-Based Vaccine Induces Protection against H9N2 Avian Influenza in Chicken
title Intranasal Immunization with a Recombinant Avian Paramyxovirus Serotypes 2 Vector-Based Vaccine Induces Protection against H9N2 Avian Influenza in Chicken
title_full Intranasal Immunization with a Recombinant Avian Paramyxovirus Serotypes 2 Vector-Based Vaccine Induces Protection against H9N2 Avian Influenza in Chicken
title_fullStr Intranasal Immunization with a Recombinant Avian Paramyxovirus Serotypes 2 Vector-Based Vaccine Induces Protection against H9N2 Avian Influenza in Chicken
title_full_unstemmed Intranasal Immunization with a Recombinant Avian Paramyxovirus Serotypes 2 Vector-Based Vaccine Induces Protection against H9N2 Avian Influenza in Chicken
title_short Intranasal Immunization with a Recombinant Avian Paramyxovirus Serotypes 2 Vector-Based Vaccine Induces Protection against H9N2 Avian Influenza in Chicken
title_sort intranasal immunization with a recombinant avian paramyxovirus serotypes 2 vector-based vaccine induces protection against h9n2 avian influenza in chicken
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9144924/
https://www.ncbi.nlm.nih.gov/pubmed/35632659
http://dx.doi.org/10.3390/v14050918
work_keys_str_mv AT yangwenhao intranasalimmunizationwitharecombinantavianparamyxovirusserotypes2vectorbasedvaccineinducesprotectionagainsth9n2avianinfluenzainchicken
AT daijing intranasalimmunizationwitharecombinantavianparamyxovirusserotypes2vectorbasedvaccineinducesprotectionagainsth9n2avianinfluenzainchicken
AT liujingjing intranasalimmunizationwitharecombinantavianparamyxovirusserotypes2vectorbasedvaccineinducesprotectionagainsth9n2avianinfluenzainchicken
AT guomengjiao intranasalimmunizationwitharecombinantavianparamyxovirusserotypes2vectorbasedvaccineinducesprotectionagainsth9n2avianinfluenzainchicken
AT liuxiaowen intranasalimmunizationwitharecombinantavianparamyxovirusserotypes2vectorbasedvaccineinducesprotectionagainsth9n2avianinfluenzainchicken
AT hushunlin intranasalimmunizationwitharecombinantavianparamyxovirusserotypes2vectorbasedvaccineinducesprotectionagainsth9n2avianinfluenzainchicken
AT gumin intranasalimmunizationwitharecombinantavianparamyxovirusserotypes2vectorbasedvaccineinducesprotectionagainsth9n2avianinfluenzainchicken
AT hujiao intranasalimmunizationwitharecombinantavianparamyxovirusserotypes2vectorbasedvaccineinducesprotectionagainsth9n2avianinfluenzainchicken
AT huzenglei intranasalimmunizationwitharecombinantavianparamyxovirusserotypes2vectorbasedvaccineinducesprotectionagainsth9n2avianinfluenzainchicken
AT gaoruyi intranasalimmunizationwitharecombinantavianparamyxovirusserotypes2vectorbasedvaccineinducesprotectionagainsth9n2avianinfluenzainchicken
AT liukaituo intranasalimmunizationwitharecombinantavianparamyxovirusserotypes2vectorbasedvaccineinducesprotectionagainsth9n2avianinfluenzainchicken
AT chenyu intranasalimmunizationwitharecombinantavianparamyxovirusserotypes2vectorbasedvaccineinducesprotectionagainsth9n2avianinfluenzainchicken
AT liuxiufan intranasalimmunizationwitharecombinantavianparamyxovirusserotypes2vectorbasedvaccineinducesprotectionagainsth9n2avianinfluenzainchicken
AT wangxiaoquan intranasalimmunizationwitharecombinantavianparamyxovirusserotypes2vectorbasedvaccineinducesprotectionagainsth9n2avianinfluenzainchicken